Innate immune deficiency of extremely premature neonates can be reversed by interferon-γ

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Tissières, Pierre ^a,b   Ochoda, Agnieszka ^a,b   Dunn Siegrist, Irène ^a,b   Drifte, Geneviève ^a,b   Morales, Michel ^a   Pfister, Riccardo ^a   Berner, Michel ^a   Pugin, Jérôme ^a,b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; GAMMA INTERFERON; PROTEIN MD 2; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; IMMUNOGLOBULIN RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; DISEASE ASSOCIATION; ESCHERICHIA COLI; FEMALE; GESTATIONAL AGE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNITY; IMMUNOMODULATION; INCUBATION TIME; INFANT; INFLAMMATION; LEUKOCYTE; LEUKOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; OPSONIZATION; PREMATURITY; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SEPSIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TERM BIRTH; UMBILICAL CORD BLOOD; BODY WEIGHT; CELL LINE; CLINICAL TRIAL; COMPARATIVE STUDY; CYTOLOGY; EXTREMELY LOW BIRTH WEIGHT; FETUS BLOOD; FLOW CYTOMETRY; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; NEWBORN; NONPARAMETRIC TEST; PHAGOCYTOSIS; PHYSIOLOGY; PREGNANCY;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; POSIBACTERIA;

BODY WEIGHT; CELL LINE; FEMALE; FETAL BLOOD; FLOW CYTOMETRY; GESTATIONAL AGE; HUMANS; IMMUNITY, INNATE; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INTERFERON-GAMMA; LEUKOCYTES; MALE; PHAGOCYTOSIS; PREGNANCY; RECEPTORS, IMMUNOLOGIC; SEPSIS; STATISTICS, NONPARAMETRIC;

EID: 84858061123     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032863     Document Type: Article

References (54)

1. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, et al. (2002) Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 110: 285-291.
2. Venkatesh MP, Placencia F, Weisman LE, (2006) Coagulase-negative staphylococcal infections in the neonate and child: an update. Semin Pediatr Infect Dis 17: 120-127.
3. Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, et al. (2004) Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. Jama 292: 2357-2365.
4. Hilgendorff A, Schmidt R, Bohnert A, Merz C, Bein G, et al. (2005) Host defence lectins in preterm neonates. Acta Paediatr 94: 794-799.
5. Dyke MP, Forsyth KD, (1994) Plasma fibronectin levels in extremely preterm infants in the first 8 weeks of life. J Paediatr Child Health 30: 36-39.
6. Elson G, Dunn-Siegrist I, Daubeuf B, Pugin J, (2007) Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria. Blood 109: 1574-1583.
7. Pugin J, Heumann ID, Tomasz A, Kravchenko VV, Akamatsu Y, et al. (1994) CD14 is a pattern recognition receptor. Immunity 1: 509-516.
8. Fusunyan RD, Nanthakumar NN, Baldeon ME, Walker WA, (2001) Evidence for an innate immune response in the immature human intestine: toll-like receptors on fetal enterocytes. Pediatr Res 49: 589-593.
9. Levy O, Zarember KA, Roy RM, Cywes C, Godowski PJ, et al. (2004) Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J Immunol 173: 4627-4634.
10. Forster-Waldl E, Sadeghi K, Tamandl D, Gerhold B, Hallwirth U, et al. (2005) Monocyte toll-like receptor 4 expression and LPS-induced cytokine production increase during gestational aging. Pediatr Res 58: 121-124.
11. Sadeghi K, Berger A, Langgartner M, Prusa AR, Hayde M, et al. (2007) Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling. J Infect Dis 195: 296-302.
12. Wolfs TG, Dunn-Siegrist I, van't Veer C, Hodin CM, Germeraad WT, et al. (2008) Increased release of sMD-2 during human endotoxemia and sepsis: a role for endothelial cells. Mol Immunol 45: 3268-3277.
13. Docke WD, Randow F, Syrbe U, Krausch D, Asadullah K, et al. (1997) Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 3: 678-681.
14. Marodi L, (2006) Innate cellular immune responses in newborns. Clin Immunol 118: 137-144.
15. Tissieres P, Pugin J, (2009) The role of MD-2 in the opsonophagocytosis of Gram-negative bacteria. Curr Opin Infect Dis 22: 286-291.
16. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, et al. (2002) Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 347: 240-247.
17. Tyson JE, Parikh NA, Langer J, Green C, Higgins RD, (2008) Intensive care for extreme prematurity-moving beyond gestational age. N Engl J Med 358: 1672-1681.
18. Wolfs TG, Derikx JP, Hodin CM, Vanderlocht J, Driessen A, et al. (2010) Localization of the lipopolysaccharide recognition complex in the human healthy and inflamed premature and adult gut. Inflamm Bowel Dis 16: 68-75.
19. Munford RS, Pugin J, (2001) Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 163: 316-321.
20. Dembinski J, Behrendt D, Reinsberg J, Bartmann P, (2002) Endotoxin-stimulated production of IL-6 and IL-8 is increased in short-term cultures of whole blood from healthy term neonates. Cytokine 18: 116-119.
21. Hebra A, Strange P, Egbert JM, Ali M, Mullinax A, et al. (2001) Intracellular cytokine production by fetal and adult monocytes. J Pediatr Surg 36: 1321-1326.
22. Schultz C, Rott C, Temming P, Schlenke P, Moller JC, et al. (2002) Enhanced interleukin-6 and interleukin-8 synthesis in term and preterm infants. Pediatr Res 51: 317-322.
23. Tatad AM, Nesin M, Peoples J, Cheung S, Lin H, et al. (2008) Cytokine expression in response to bacterial antigens in preterm and term infant cord blood monocytes. Neonatology 94: 8-15.
24. Yerkovich ST, Wikstrom ME, Suriyaarachchi D, Prescott SL, Upham JW, et al. (2007) Postnatal development of monocyte cytokine responses to bacterial lipopolysaccharide. Pediatr Res 62: 547-552.
25. Carr R, (2000) Neutrophil production and function in newborn infants. Br J Haematol 110: 18-28.
26. Martin EL, Souza DG, Fagundes CT, Amaral FA, Assenzio B, et al. (2010) PI3Kγ kinase activity contributes to sepsis and organ damage by altering neutrophil recruitment. Am J Respir Crit Care Med [Epub ahead of print].
27. Alves-Filho JC, Freitas A, Souto FO, Spiller F, Paula-Neto H, et al. (2009) Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis. Proc Natl Acad Sci U S A 106: 4018-4023.
28. Volk HD, Reinke P, Krausch D, Zuckermann H, Asadullah K, et al. (1996) Monocyte deactivation-rationale for a new therapeutic strategy in sepsis. Intensive Care Med 22 (Suppl 4): S474-481.
29. Cavaillon JM, Adrie C, Fitting C, Adib-Conquy M, (2005) Reprogramming of circulatory cells in sepsis and SIRS. J Endotoxin Res 11: 311-320.
30. Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, et al. (2009) Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 180: 640-648.
31. Pugin J, (2007) Immunostimulation is a rational therapeutic strategy in sepsis. Novartis Found Symp 280: 21-27; discussion 27-36, 160-164.
32. Schiff DE, Rae J, Martin TR, Davis BH, Curnutte JT, (1997) Increased phagocyte Fc gammaRI expression and improved Fc gamma-receptor-mediated phagocytosis after in vivo recombinant human interferon-gamma treatment of normal human subjects. Blood 90: 3187-3194.
33. Abreu MT, Arnold ET, Thomas LS, Gonsky R, Zhou Y, et al. (2002) TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J Biol Chem 277: 20431-20437.
34. Gasparoni A, Ciardelli L, Avanzini A, Castellazzi AM, Carini R, et al. (2003) Age-related changes in intracellular TH1/TH2 cytokine production, immunoproliferative T lymphocyte response and natural killer cell activity in newborns, children and adults. Biol Neonate 84: 297-303.
35. Wegmann TG, Lin H, Guilbert L, Mosmann TR, (1993) Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 14: 353-356.
36. Hilkens CM, Vermeulen H, van Neerven RJ, Snijdewint FG, Wierenga EA, et al. (1995) Differential modulation of T helper type 1 (Th1) and T helper type 2 (Th2) cytokine secretion by prostaglandin E2 critically depends on interleukin-2. Eur J Immunol 25: 59-63.
37. Roth I, Corry DB, Locksley RM, Abrams JS, Litton MJ, et al. (1996) Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J Exp Med 184: 539-548.
38. Olson CM Jr, Bates TC, Izadi H, Radolf JD, Huber SA, et al. (2009) Local production of IFN-gamma by invariant NKT cells modulates acute Lyme carditis. J Immunol 182: 3728-3734.
39. Gordon MA, Jack DL, Dockrell DH, Lee ME, Read RC, (2005) Gamma interferon enhances internalization and early nonoxidative killing of Salmonella enterica serovar Typhimurium by human macrophages and modifies cytokine responses. Infect Immun 73: 3445-3452.
40. Hill HR, Augustine NH, Jaffe HS, (1991) Human recombinant interferon gamma enhances neonatal polymorphonuclear leukocyte activation and movement, and increases free intracellular calcium. J Exp Med 173: 767-770.
41. Marodi L, Kaposzta R, Nemes E, (2000) Survival of group B streptococcus type III in mononuclear phagocytes: differential regulation of bacterial killing in cord macrophages by human recombinant gamma interferon and granulocyte-macrophage colony-stimulating factor. Infect Immun 68: 2167-2170.
42. Group TICGDCS (1991) A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 324: 509-516.
43. Crowther CA, Harding JE, (2007) Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database Syst Rev pp. CD003935.
44. Feldhaus B, Dietzel ID, Heumann R, Berger R, (2004) Effects of interferon-gamma and tumor necrosis factor-alpha on survival and differentiation of oligodendrocyte progenitors. J Soc Gynecol Investig 11: 89-96.
45. Folkerth RD, Keefe RJ, Haynes RL, Trachtenberg FL, Volpe JJ, et al. (2004) Interferon-gamma expression in periventricular leukomalacia in the human brain. Brain Pathol 14: 265-274.
46. Carr R, Brocklehurst P, Dore CJ, Modi N, (2009) Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial. Lancet 373: 226-233.
47. Molloy EJ, O'Neill AJ, Grantham JJ, Sheridan-Pereira M, Fitzpatrick JM, et al. (2005) Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function. Pediatr Res 57: 806-812.
48. Matoba N, Yu Y, Mestan K, Pearson C, Ortiz K, et al. (2009) Differential patterns of 27 cord blood immune biomarkers across gestational age. Pediatrics 123: 1320-1328.
49. Shuto T, Furuta T, Cheung J, Gruenert DC, Ohira Y, et al. (2007) Increased responsiveness to TLR2 and TLR4 ligands during dimethylsulfoxide-induced neutrophil-like differentiation of HL-60 myeloid leukemia cells. Leuk Res 31: 1721-1728.
50. Pugin J, Stern-Voeffray S, Daubeuf B, Matthay MA, Elson G, et al. (2004) Soluble MD-2 activity in plasma from patients with severe sepsis and septic shock. Blood 104: 4071-4079.
51. Tissieres P, Dunn-Siegrist I, Schappi M, Elson G, Comte R, et al. (2008) Soluble MD-2 is an acute-phase protein and an opsonin for Gram-negative bacteria. Blood 111: 2122-2131.
52. Dunn-Siegrist I, Leger O, Daubeuf B, Poitevin Y, Depis F, et al. (2007) Pivotal involvement of Fcgamma receptor IIA in the neutralization of lipopolysaccharide signaling via a potent novel anti-TLR4 monoclonal antibody 15C1. J Biol Chem 282: 34817-34827.
53. Ramet M, Manfruelli P, Pearson A, Mathey-Prevot B, Ezekowitz RA, (2002) Functional genomic analysis of phagocytosis and identification of a Drosophila receptor for E. coli. Nature 416: 644-648.
54. Perneger TV, (1998) What's wrong with Bonferroni adjustments. Bmj 316: 1236-1238.